Quantcast

Latest Hisamitsu Pharmaceutical Co. Inc. Stories

2014-06-18 12:34:08

LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Hormone Replacement Therapy (HRT) Industryhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/hormone_replacement_therapy_hrt.html This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and...

2014-01-08 12:29:08

LONDON, Jan. 8, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Global Dermatophytic Onychomycosis Therapeutics Market 2012-2016 TechNavio's analysts forecast the Global Dermatophytic Onychomycosis Therapeutics market to grow at a CAGR of 7.28 percent over the period 2012-2016. One of the key factors contributing to this market growth is the strong and promising pipeline. The Global Dermatophytic Onychomycosis Therapeutics market has also been...

2009-08-27 20:51:00

TOSU, Saga, Japan and MIAMI, Aug. 27 /PRNewswire-FirstCall/ -- Hisamitsu Pharmaceutical Co., Inc. (TSE: 4530) and Hisamitsu U.S., Inc. today announced the completion of their acquisition of Noven Pharmaceuticals, Inc. pursuant to a short form merger of Northstar Merger Sub, Inc., a wholly owned subsidiary of Hisamitsu U.S., Inc., with and into Noven. Pursuant to the Agreement and Plan of Merger among the companies, at the effective time of the merger all remaining outstanding shares of...

2009-08-27 07:23:00

TOSU, SAGA, Japan, Aug. 27 /PRNewswire/ -- Hisamitsu Pharmaceutical Co., Inc. (TSE: 4530) today announced the expiration of the subsequent offering period and completion of the tender offer for all outstanding shares of Noven Pharmaceuticals, Inc. (Nasdaq: NOVN) common stock at a price per share of $16.50. The subsequent offering period expired at 12:00 midnight, New York City time, on Wednesday, August 26, 2009 and was not extended. As of such time, an aggregate of 22,320,889 shares of...

2009-08-20 07:14:00

TOSU, SAGA, Japan, Aug. 20 /PRNewswire/ -- Hisamitsu Pharmaceutical Co., Inc. (TSE: 4530), Hisamitsu U.S., Inc. and Northstar Merger Sub, Inc. today announced the completion of the initial tender offer period for all outstanding shares of Noven Pharmaceuticals, Inc. (Nasdaq: NOVN) common stock and the commencement of a subsequent offering period that will expire at 12:00 midnight on Wednesday, August 26, 2009, unless extended. As previously announced, on July 23, 2009, Hisamitsu...

2009-08-13 11:56:00

TOSU, SAGA, Japan, Aug. 13 /PRNewswire/ -- Hisamitsu Pharmaceutical Co., Inc. (TSE: 4530), Hisamitsu U.S., Inc. and Northstar Merger Sub, Inc., today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), at 11:59 p.m., New York City time, on August 12, 2009, with respect to the previously announced proposed acquisition of Noven Pharmaceuticals, Inc. (Nasdaq: NOVN). Hisamitsu, through its wholly owned...

2009-07-23 06:04:00

TOSU, SAGA, Japan, July 23 /PRNewswire/ -- Hisamitsu Pharmaceutical Co., Inc. (TSE: 4530), Hisamitsu U.S., Inc. and Northstar Merger Sub, Inc., today commenced the cash tender offer to purchase all outstanding shares of common stock of Noven Pharmaceuticals, Inc. (Nasdaq: NOVN) contemplated by the Agreement and Plan of Merger executed and publicly announced by Hisamitsu and Noven on July 14, 2009. Upon the successful closing of the tender offer, shareholders of Noven will receive $16.50...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.